Synthesis of 2′-deoxy-2′-fluoroguanyl-(3′,5′)-guanosine

Nucleosides, Nucleotides and Nucleic Acids

Volumn 21, Issue 11-12, 2002, Pages 765-774

  Maruyama, Tokumi ^a   Kozai, Shigetada ^a   Nakamura, Kazuo ^b   Irie, Masachika ^c  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c HOSHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2' DEOXY 2' FLUOROGUANYL 3',5' GUANOSINE; GUANOSINE DERIVATIVE; UNCLASSIFIED DRUG; 2' DEOXY 2' FLUOROGUANYL (3',5') GUANOSINE; 2'-DEOXY-2'-FLUOROGUANYL-(3',5')-GUANOSINE; DRUG DERIVATIVE; GUANOSINE;

ARTICLE; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; HYDROLYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; SYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN;

DRUG DESIGN; GUANOSINE; MOLECULAR STRUCTURE;

EID: 0036908689     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1081/NCN-120016479     Document Type: Article

References (22)

1. Ledoux, L.; Baltus, E. Experientia 1954, 10, 500-501.
2. Ledoux, L. Nature 1955, 175, 258-259.
3. Ledoux, L. Nature 1955, 176, 36-37.
4. a) Youle, R.J.; D'Alessio, G. Ribonucleases. Structures and Funcions; Academic Press: New York, 1997; 491-514.
5. b) Irie, M.; Nitta, K.; Nonaka, T. Cell. Mol. Life Sci. 1998, 54, 775-784.
6. Vitagliano, L.; Adinolfi, S.; Riccio, A.; Sica, F.; Zagari, A. Protein Sci. 1998, 7, 1691-1699.
7. Vitagliano, L.; Merlino, A.; Zagari, A.; Mazzarella, L. Protein Sci. 2000, 9, 1217-1225.
8. Aguilar, C.F.; Thomas, P.J.; Mills, A.; Moss, D.S.; Palmer, R.A.J. Mol. Biol. 1992, 224, 265-267.
9. Koepke, J.; Maslowska, M.; Heinemann, U.; Saenger, W. J. Mol. Biol. 1989, 206, 475-488.
10. Nonaka, T.; Nakamura, K.T.; Uesugi, S.; Ikehara, M.; Irie, M.; Mitsui, Y. Biochemistry 1993, 32, 11,825-11,837.
11. a) Ikehara, M.; Maruyama, T.; Miki, H. Tetrahedron 1978, 34, 1133-1188.
12. b) Ikehara, M. Heterocycles 1984, 21, 75-90 and the references cited therein.
13. Enzymatic synthesis of purine 2′-deoxy-2′-fluororibosides has been reported by Welcome Research Laboratories. Tuttle, J.V.; Tisdale, M.; Krenitsky, T.A. J. Med. Chem. 1993, 36, 119-125.
14. Olsen, D.B.; Benseler, H.A.; Pieken, W.A.; Eckstein, F. Biochemistry 1991, 30, 9735-9741.
15. a) Fukukawa, K.; Ueda, T.; Hirano, T. Chem. Pharm. Bull. 1983, 31, 1582-1592.
16. b) Sato, Y.; Maruyama, T.; Honjo, M. ibid. 1989, 37, 1604-1608.
17. Robins, M.J.; Wilson, J.S.; Sawyer, L.; James, M.N.G. Can. J. Chem. 1983, 61, 1911-1920.
18. Baker, D.C.; Kumar, S.D.; Waites, W.J.; Arnett, G.; Shannon, W.M.; Higuchi, W.I.; Lambert, W.J.J. Med. Chem. 1984, 27, 270.
19. a) Ikehara M.; Maruyama, T. Tetrahedron 1975, 31, 1369-1372.
20. Ikehara, M.; Miki, H. Chem. Pharm. Bull. 1978, 26, 2449-2453.
21. Kawasaki, A.M.; Casper, M.D.; Freier, S.M.; Lesnik, E.A.; Zounes, M.C.; Cummins, L.L.; Gonzalez, C.; Cook, P.D.J. Med. Chem. 1993, 36, 831-841.
22. Atkinson, T.; Smith, M.A Practical Approach. In Oligonucleotide Synthesis; Gait, M.J., Ed.; IRL Press: Oxford, 1984; 35-81.